NECN Lung NSSG April 2012 Managing Solitary Brain Metastases from NSCLC Dr Paula Mulvenna Consultant Clinical Oncologist Northern Centre for Cancer Care.

Slides:



Advertisements
Similar presentations
Post-operative Radiotherapy for Esophageal Cancer Parag Sanghvi, M.D., M.S.P.H. Department of Radiation Medicine Esophageal Care Conference 3/26/2007.
Advertisements

Treatment in Advanced Non-Small Cell Lung Cancer.
Cancer of Unknown Primary Dr Chris Jones Consultant Medical Oncologist North of England Cancer Network Annual Conference 20 September 2013.
« A Clear cell sarcoma » FN. 25 year-old male January cm mass on the medial side of the right heel Early August cm clinical right.
Multidisciplinary approaches on chest tumors Radiation Oncology Case Reports.
Staging. Treatment by Stage For early stage lung cancers, surgery or radiation alone For larger tumors (>4 cm) and N+, chemotherapy should be added.
Do you know what ’ s in people ’ s head?. Brain tumors 72 male 72 male HPI: presents to E.R. with history of confusion, change of personality, left sided.
“No Air” Management of Lung Cancer
S Strong 1,2, NS Blencowe 1,2,T Fox 1, C Reid 3, T Crosby 4, H.Ford 5, J M Blazeby 1,2 1 School of Social and Community Medicine, Canynge Hall, University.
First HAYAT Annual Patients Forum – 21 st March 2010 – SAS, Kuwait First HAYAT Annual Patients Forum 21 st March 2010 Al Hashimi II Ballroom – SAS Hotel.
Matthew Kilmurry, M.D. St. Mary’s General Hospital Grand River Hospital.
62 years old man Main complaint: Back pain at night but not during the day Loss of appettite Weight loss.
Advances in the Treatment of Lung Cancer Sin Chong Lau Consultant in Medical Oncology.
Synovial sarcoma- which patients don’t need adjuvant treatment? Khan M, Rankin KS, Beckingsale TB, Todd R, Gerrand CH North of England Bone and Soft Tissue.
Defining the Colorectal Surgeons role in patients with colorectal cancer and limited metastatic disease Jose G. Guillem, MD, MPH Department of Surgery.
AJCC Staging Moments AJCC TNM Staging 7th Edition Lung Case #3 Contributors: Valerie W. Rusch, MD Memorial Sloan-Kettering Cancer Center, New York, New.
Joint Hospital Surgical Grand Round 21 st July, 2012 RH.
The role of surgery in the management of mesothelioma Mr Martyn Carr Consultant Thoracic Surgeon Liverpool Heart and Chest Hospital.
Palliative Chemotherapy Dr. Oscar S. Breathnach Consultant Medical Oncologist Palliative Care Multidisciplinary Study Day Beaumont Hospital Sept. 19 th,
© Copyright 2003 Cardinal Health, Inc. or one of its subsidiaries. All rights reserved. PET in Colorectal Cancer Early detection of disease Precise Staging.
Progression-Free Interval After RFA of Lung Tumors Size Matters
A randomized trial of prophylactic cranial irradiation (PCI) versus no PCI in extensive disease small cell lung cancer after a.
SWISS TUMOR BOARD Lung Cancer March 26, 2009 Novotel Bern Prof. Dr. Mahmut Ozsahin Lausanne University Medical Center (CHUV), Lausanne.
SURGERY FOR NSCLC GREG CHRISTODOULIDES MD, FACS, FCCP, FESTS
Resection For Lung Metastases M62 Coloproctology Course.
National Oesophago–Gastric Cancer Audit Key Findings from 2014 Annual Report and Progress Report Georgina Chadwick Clinical Research Fellow.
Multimodality therapy for locally advanced thymomas: a cohort study of prognostic factors from a European multicentric database Dr. GIOVANNI LEUZZI Department.
(4) Radiation Therapy Oncology Group (RTOG)
SYNCHRONOUS COLORECTAL AND LIVER RESECTION J Peter A Lodge MD FRCS HPB and Transplant Unit St James’s University Hospital Leeds LS9 7TF 2006 Association.
Alessandra Fabi Brain Metastases: current and future options Brain Metastases: current and future options Roma, 16 Novembre 2006.
Hanan.A.Eltyb Incidence Approximately 15% of bronchogenic carcinomas. In the year 2013, an estimated new cases will be diagnosed at USA.
Management of Recurrent and Advanced Tumours: When are Tumours Resectable, and Multidisciplinary Management Dr. Andrew McFadden Surgical Oncology.
Management of the primary in Stage IV colorectal cancer Erin Kennedy, MD, PhD, FRCSC Colorectal Surgery Mount Sinai Hospital University of Toronto.
Synchronous Metastasis on Staging/Surveillance CT chest abdomen & Pelvis + CEA + MRI Liver /PET-CT Synchronous Metastasis on Staging/Surveillance CT chest.
1 David R. Gandara, MD University of California, Davis Comprehensive Cancer Center Evaluating Well-designed vs Poorly- designed Randomized Trials.
Network Audit Patients with Confirmed Small Cell Lung Cancer Who Did Not Receive Chemotherapy Dr D N Leitch On Behalf of Lung Cancer NSSG NECN.
Cancer of the Head and Neck and HPV Infection Andrew Urquhart MD, FACS Dept. Otolaryngology/Head and Neck Surgery Marshfield Clinic.
Anaplastic thyroid cancer based on ATA guideline for Management of Patients with ATC. Thyroid. 2012;22: R3 이정록.
Role of Radiation Therapy in Brain metastasis Bongkot Supawongwattana, M.D. Division of Therapeutic Radiology and Oncology, Faculty of Medicine, Chiang.
Operative Management of Osteosarcoma Patients with Pulmonary Metastasis Jen Kramer, MD R2 Swedish Medical Center February 2011.
Pt ZJ 19yo M that presented to Seattle Children’s for evaluation of 3 lesions found on recent PET CT ◦ One large mass in the posterior mediastinum just.
Surgery for Metastatic Brain Tumor from Breast Cancer
SRS/SRT AUDIT Dr Sarah Pascoe Neuro-Oncology Study Day 8 th June 2007.
Authors: Syed H. Jafri ¹, Angel I. Blanco¹, Bonnie A. Labdi², Shan Guo¹. UT Houston department of medicine, Division of Oncology Department of Pharmacy.
How clinicians use data to make an impact on clinical outcomes Dr Mick Peake Clinical Lead, National Cancer Intelligence Network Consultant & Senior Lecturer.
Neoadjuvant chemotherapy in the treatment of NSCLC Department of Thoracic Oncology, University Hospital Ghent, Belgium Current Opinion in Oncology 2007,
SCTS Education day “Radiotherapy in 2016”
Brain Metastases Dr Saiqa Spensley.
SMDT SMDT SMDT Synchronous Metastasis on Staging/Surveillance
Multi-station N2 Ca Lung
Brain imaging prior to lung cancer resection
CASE 1: Management of metastatic disease in a resource-limited setting
Short-term outcome of neo-adjuvant chemotherapy
Delivery of systemic therapy in Gloucestershire for NSCLC
Results of Definitive Radiotherapy in Anal Canal Carcinoma
Analysis of referral patterns and regional neuro-oncology multi-disciplinary team decisions in brain metastasis Dr Kamalram THIPPU JAYAPRAKASH, Dr Javier.
Bronchial Carcinoma Part 2
1 Maidstone and Tunbridge Wells NHS Trust (Kent Oncology Centre)
Brain imaging prior to lung cancer resection
Compassionate People World Class Care
Treatment With Continuous, Hyperfractionated, Accelerated Radiotherapy (CHART) For Non-Small Cell Lung Cancer (NSCLC): The Weston Park Hospital Experience.
Prognosis of younger patients in non-small cell lung cancer
Junliang Liu, M.D., M.Sc. Ph.D., FRCPC Assistant Professor
Improved survival outcomes after resection of ductal adenocarcinoma in the body and tail of the pancreas: A single center 10 years’ experience Seong.
The Nuances of Staging Lung cancer Gerard A
James D Luketich, Michael E Burt  The Annals of Thoracic Surgery 
General strategies of Cancer Treatment and evaluation of Response
Neuro-Oncology Stan Rice 2002.
Surgical resection of metachronous liver metastases
Presentation transcript:

NECN Lung NSSG April 2012 Managing Solitary Brain Metastases from NSCLC Dr Paula Mulvenna Consultant Clinical Oncologist Northern Centre for Cancer Care

NECN Lung NSSG April 2012 This Talk: Prevalence of solitary brain metastases Case histories Investigation – mandatory modalities Patients suitable for aggressive (radical) management Pathway Summary

NECN Lung NSSG April 2012 Incidence – a Global issue 2002: –10.2 million new cancers worldwide –1.35 million lung cancers 2020 –15 million new cases cancer –2 million lung 50% of these will develop intracranial metastatic disease Parkin et al CA Cancer J Clin 2005 Patients with brain metastases from lung cancer: –USA: ~85,000 patients per annum –UK: ~40,000 patients per annum 35% have solitary metastasis 65% multiple metastases Median survival < 6m

NECN Lung NSSG April 2012 Incidence, a Local Issue: NCIN e-atlas

NECN Lung NSSG April 2012 Crude Incidence, a Local Issue: NSCLC Referrals (to PMM) since (n=1810) Treatment Intent: –Palliative – 83% –Radical – 17% 10% presented with brain metastases 24% of those with stage III disease have then developed brain metastases (after combined modality treatment up front) i.e. in my day to day practice: 215 patients with NSCLC + Brain metastases between –1 per fortnight

NECN Lung NSSG April 2012 Case History 1 67 year old female – non-smoker Cough Feb 2010 RUL adenocarcinoma T2 N1M0 Staging – aiming for radical surgical approach… until CT head….. March 2010

NECN Lung NSSG April 2012 Case History 1 cont’d Chemotherapy (JG) Radiological Almost CR PS 0/1 (KPS 90) ?Role for radical management of intra and extra cranial Disease PET (renal CT) MRI brain Sept 2010 Radical RT to RUL remnant Oct 2010 Gamma Knife SRS to brain met Nov 2010 Intra-thoracic Local recurrence March 2012 – brain clear Further systemic treatment

NECN Lung NSSG April 2012 Case History 2 57 year old male Feb 2011: Post chest pain + haemoptysis Life long smoker (50 pack year) Alcohol xs; Lives alone RUL squamous cell cancer 2010 T3N2M0 (CT head clear) PS 1 (but other tobacco related co morbidities) Gem Carbo chemo Good PR Radical RT – Good PR Aug 2011

NECN Lung NSSG April 2012 Case History 2 cont’d Feb 2012 – unsteady, falls ++ MRI brain – 5x4 cm right cerebellar cystic mass Extra cranial disease - active

NECN Lung NSSG April 2012 Micro-Surgical resection or Stereotactic Radiosurgery (SRS)? For solitary metastasis – comparable outcomes –Kalkanis et al J. Neuro Oncology 2010; 96(1): Surgical series: superficial, larger, midline shift –Best results if complete en bloc resection –Where possible, avoid piecemeal resection Do less well if >9.5cm or if removed piecemeal

NECN Lung NSSG April 2012 Micro-Surgical resection or Stereotactic Radiosurgery (SRS)? SRS smaller (<3cm) Deep seated Less mid line shift Both (Sx or SRS) provide comparable local control and overall survival (ms >10m) Addition of WBRT – further intra cranial control; no further benefit seen in OS

NECN Lung NSSG April 2012 Pathway Patient Presents with possible solitary metastasis from confirmed NSCLC –PS 0/1 (KPS 90 – 100) –MRI Head –Full Staging of extra-cranial Disease - PET-CT Lung MDT Neuro-Oncology MDT (central) Decision re microsurgical resection or SRS De novo presentation - ?surgery for thoracic component / non-surgical oncological radical approach

NECN Lung NSSG April 2012 Summary Solitary metastasis Good PS (ECOG 0-1) No extra cranial metastatic disease Radically treatable primary